Dr. Humaid Bin Harmal Al Shamsi

Medical Degrees

• MD (with Honours) — University of Cork, The National University of Ireland, 2005
• Internal Medicine Residency — McMaster University, Hamilton, Canada

Fellowships & Special Training

• Fellowship in Medical Oncology — McMaster University, Canada, 2011
• Subspecialty Combined Fellowship in Gastrointestinal and Palliative Oncology — McMaster University, Canada, 2013

Certifications & Accreditations

• FRCP(C) — Royal College of Physicians and Surgeons of Canada (Medical Oncology)
• FRCP(C) — Royal College of Physicians and Surgeons of Canada (Internal Medicine)
• MRCP (UK) — Specialist Certification Examination in Medical Oncology, Royal College of Physicians of the United Kingdom
• ABIM Board Certified — American Board of Internal Medicine
• Fellow, American College of Physicians (UK)

Major Conditions Treated

• Gastrointestinal Cancers (Colon, Rectal, Gastric, Pancreatic, Liver)
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Gynaecologic Cancers (Ovarian, Cervical, Endometrial)
• Thyroid Cancer
• Lymphoma and Hematologic Malignancies
• Rare Tumours and Advanced Solid Tumours

Sub-specialties

• Gastrointestinal Oncology: The only UAE-certified GI oncologist, leading personalised chemotherapy and targeted therapy protocols — a trusted Medical Oncologist Dubai for international patients seeking advanced GI cancer treatment.
• Palliative & Supportive Oncology: First Emirati trained in palliative care, integrating symptom control and quality-of-life management alongside curative therapy.
• Precision Oncology: Expert in molecular profiling, biomarker-driven therapy, and immunotherapy — sought by patients researching the best Medical Oncologist in UAE for cancer treatment.

Advanced Procedures & Treatments

• Targeted Therapy (EGFR, HER2, ALK, BRAF, VEGF inhibitors)
• Immunotherapy / Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4)
• Personalised Chemotherapy Regimens (FOLFIRI, FOLFOX, FOLFIRINOX)
• Hormone Therapy (Breast, Prostate Cancer)
• Molecular Tumour Profiling & Liquid Biopsy
• Tele-Oncology Consultations for International Patients

Current Affiliation

• Burjeel Medical City / Burjeel Cancer Institute, UAE — Founder & Director, Medical Oncology Service (Present)
• Emirates Oncology Society — President
• University of Sharjah, College of Medicine — Adjunct Clinical Professor of Oncology

Past Affiliations

• Al Zahra Hospital, Dubai — Consultant Oncologist, 2017–2021
• Tawam Hospital, Al Ain — Consultant Oncologist, 2018–2020
• MD Anderson Cancer Center, Houston, USA — Consultant & Researcher in Oncology, 2013–2017
• University of Texas, USA — Faculty Appointment, 2013–2017
• McMaster University, Canada — Assistant Professor, 2013–2017

Academic & Research Roles

• Adjunct Clinical Professor of Oncology — University of Sharjah
• Advisor & Member, Governmental Committees — Department of Health Abu Dhabi, Dubai Health Authority, Ministry of Health UAE
• Member, Steering Committee on National Cancer Control Indicators (since January 2018)

Key Achievements

• Identified a novel subtype of colon cancer in 2017 after analysing genetic data from 9,000+ colon cancer patients
• Authored "Cancer in the Arab World" (2021) and co-authored "Rare Tumors" textbook (2018)
• Published the first international study on cancer-patient management during the COVID-19 pandemic
• 1st Graduate of Sheikh Khalifa bin Zayed Program for Outstanding UAE Physicians (2016)
• 100+ international peer-reviewed publications

National & International Awards

• Outstanding Researcher of the Year Award — Emirates Medical Association, 2020
• 1st Graduate, Sheikh Khalifa bin Zayed Program for Outstanding UAE Physicians, 2016
• Outstanding Senior Resident of the Year Award (MSA), 2012
• Jeff Ginsberg Subspecialty Resident Award, 2012
• Internal Medicine Chief's Cup, 2009–2010
• Certificate of Appreciation — UAE Embassy in London, UK
• Certificate of Appreciation — UAE Embassy in Washington D.C., USA

Professional Memberships

• President, Emirates Oncology Society (EOS)
• American Society of Clinical Oncology (ASCO)
• European Society for Medical Oncology (ESMO)
• International Society of Gastrointestinal Oncology (ISGIO)
• Canadian Medical Protective Association
• UAE Medical Association
• Fellow, Royal College of Physicians and Surgeons of Canada
• Fellow, American College of Physicians (UK)

Published Papers (Selected)

• Al-Shamsi HO. "Mammography screening for breast cancer—the UK Age trial." The Lancet Oncology. 2020;21(11):e505.
• Al-Shamsi HO, Abu-Gheida I, Abdulsamad AS, et al. "A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic." The Oncologist. 2020.
• Al-Shamsi HO. "COVID-19 Vaccination for Cancer Patients, What Oncologists and Cancer Patients Need to Know?" Journal of Oncology Research Review & Reports. 2020;SRC/JONRR-114.
• Al-Shamsi HO, Al Farsi A, Ellis PM. "Stage III non-small-cell lung cancer: Establishing a benchmark for the proportion of patients suitable for radical treatment." Clin Lung Cancer. 2014 Jul;15(4):274-80.
• Al-Shamsi HO, Anjum M, Al Farsi AM, et al. "Thrombotic events in metastatic colorectal cancer patients treated with FOLFIRI plus bevacizumab." 2013.
• Al-Shamsi HO, Iqbal F, Al-Saad MS, et al. "The Burden of Gynecologic Cancers in the UAE." Journal of Oncology Research Review & Reports. 2021;SRC/JONRR-147.
• Bukhari N, Alshangiti A, Tashkandi E, Algarni M, Al-Shamsi HO, Al-Khallaf H. "Fluoropyrimidine-Induced Severe Toxicities Associated with Rare DPYD Polymorphisms." Clinics and Practice. 2021;11(3):467-471.
• Co-author, "Cancer in the Arab World" (Book, 2021)
• Co-author, "Rare Tumors" (Book, 2018)

Ongoing Research & Clinical Interests

• Molecular profiling and personalised treatment in GI malignancies
• Cancer epidemiology in the Arab world
• Tele-oncology and virtual cancer care models for the MENA region
• Outcomes of immunotherapy in solid tumours
• National cancer control indicators and UAE cancer registries

*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.